Literature DB >> 16698415

Cushing's syndrome.

John Newell-Price1, Xavier Bertagna, Ashley B Grossman, Lynnette K Nieman.   

Abstract

Cushing's syndrome results from lengthy and inappropriate exposure to excessive glucocorticoids. Untreated, it has significant morbidity and mortality. The syndrome remains a challenge to diagnose and manage. Here, we review the current understanding of pathogenesis, clinical features, diagnostic, and differential diagnostic approaches. We provide diagnostic algorithms and recommendations for management.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16698415     DOI： 10.1016/S0140-6736(06)68699-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


  320 in total

1.  [Adrenal tumors. Principles of diagnostics and operative treatment].

Authors:  A Gonsior; H Pfeiffer; D Führer; E Liatsikos; T Schwalenberg; J-U Stolzenburg
Journal:  Urologe A       Date:  2010-05       Impact factor: 0.639

2.  Emotional and psychological trauma in refugees arriving in Germany in 2015.

Authors:  E Ullmann; A Barthel; S Taché; A Bornstein; J Licinio; S R Bornstein
Journal:  Mol Psychiatry       Date:  2015-11-03       Impact factor: 15.992

3.  Effectiveness of Metyrapone in Treating Cushing's Syndrome: A Retrospective Multicenter Study in 195 Patients.

Authors:  Eleni Daniel; Simon Aylwin; Omar Mustafa; Steve Ball; Atif Munir; Kristien Boelaert; Vasileios Chortis; Daniel J Cuthbertson; Christina Daousi; Surya P Rajeev; Julian Davis; Kelly Cheer; William Drake; Kirun Gunganah; Ashley Grossman; Mark Gurnell; Andrew S Powlson; Niki Karavitaki; Isabel Huguet; Tara Kearney; Kumar Mohit; Karim Meeran; Neil Hill; Aled Rees; Andrew J Lansdown; Peter J Trainer; Anna-Elisabeth H Minder; John Newell-Price
Journal:  J Clin Endocrinol Metab       Date:  2015-09-09       Impact factor: 5.958

4.  Treatment of pituitary tumours in 2014: Advances in therapy of adenomas secreting GH, ACTH and TSH.

Authors:  Annamaria Colao
Journal:  Nat Rev Endocrinol       Date:  2014-12-23       Impact factor: 43.330

5.  Factors predicting the duration of adrenal insufficiency in patients successfully treated for Cushing disease and nonmalignant primary adrenal Cushing syndrome.

Authors:  Alessandro Prete; Rosa Maria Paragliola; Filomena Bottiglieri; Carlo Antonio Rota; Alfredo Pontecorvi; Roberto Salvatori; Salvatore Maria Corsello
Journal:  Endocrine       Date:  2016-07-09       Impact factor: 3.633

6.  Incidence of Cushing's syndrome and Cushing's disease in commercially-insured patients <65 years old in the United States.

Authors:  Michael S Broder; Maureen P Neary; Eunice Chang; Dasha Cherepanov; William H Ludlam
Journal:  Pituitary       Date:  2015-06       Impact factor: 4.107

7.  Ectopic Cushing's syndrome due to retroperitoneal ACTH-producing paragangliomas.

Authors:  Fan Chen; Xiangyu Wang; Yang Wang; Hui Meng; Xinguo Hou; Yaofeng Zhu; Wei Gao; Xuewen Jiang; Shouzhen Chen; Zhaocun Zhang; Zhichuan Zou; Tianyi He; Yue Yang; Kejia Zhu; Yong Wang; Yaxiao Liu; Jianfeng Cui; Benkang Shi; Gang Yin
Journal:  Can Urol Assoc J       Date:  2016-09-13       Impact factor: 1.862

Review 8.  Cushing's syndrome: from physiological principles to diagnosis and clinical care.

Authors:  Hershel Raff; Ty Carroll
Journal:  J Physiol       Date:  2015-01-05       Impact factor: 5.182

9.  The pituitary function of androgen receptor constitutes a glucocorticoid production circuit.

Authors:  Junko Miyamoto; Takahiro Matsumoto; Hiroko Shiina; Kazuki Inoue; Ichiro Takada; Saya Ito; Johbu Itoh; Takeo Minematsu; Takashi Sato; Toshihiko Yanase; Hajime Nawata; Yoshiyuki R Osamura; Shigeaki Kato
Journal:  Mol Cell Biol       Date:  2007-04-30       Impact factor: 4.272

10.  Testosterone and bioavailable testosterone help to distinguish between mild Cushing's syndrome and polycystic ovarian syndrome.

Authors:  M E Pall; M C Lao; S S Patel; M L Lee; D E Ghods; D W Chandler; T C Friedman
Journal:  Horm Metab Res       Date:  2008-09-25       Impact factor: 2.936
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.